A Trial of LY3056480 in Patients With SNLH

NCT05061758 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Stopped Study put on hold

Conditions

Sensorineural Hearing Loss

Interventions

DRUG: LY3056480

Sponsor

Audion Therapeutics BV